Italy looks at medicine price cuts while Spain moves on discounts
This article was originally published in Scrip
Executive Summary
The Italian government is likely to introduce medicine price cuts in a bid to save €2 billion on drug spending. Meanwhile, the Spanish cabinet recently approved a bill that will see discounts applied to state-financed patented medicines, and France is to bring forward a range of pricecuts that among other things could affect Merck & Co's antihypertensive Cozaar (losartan).